Lexpos News

In the recent CPCF funding settlement, it was agreed that changes would be made to the Pharmacy Contraception Service (PCS) to include drospirenone within the list of contraceptives which can be supplied and to add oral emergency contraception (EC) to the service. These changes to the service necessitate updates to the service specification, the existing [...]

The post Updated PCS service spec and PGDs published ahead of changes later in the year appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video introducing the Pricing Audit Team (PAT). The Pricing Audit Team undertake monthly audit checks to verify the accuracy of NHS pricing across prescriptions and the Margin Survey. For prescription pricing, pharmacy accounts are audited [...]

The post Funding & Reimbursement Shorts: Introduction to Pricing Audit Team appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 July 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Betaxolol 0.25% eye drops 0.25ml unit dose preservative free Betoptic® 0.25% eye drops [...]

The post 3 products re-classified as special containers from July 2025 appeared first on Community Pharmacy England.

With the conclusion of the NHS 10-Year Health Plan imminent, this is a critical time for community pharmacy and it is important that we focus on the future, including looking at negotiating priorities to further leverage community pharmacy’s position. Pharmacy owners across the West Midlands and North West are invited to ‘Future of Pharmacy’ workshop [...]

The post West Midlands and North Western Pharmacy Owners: Book on your local Future of Pharmacy workshop appeared first on Community Pharmacy England.

From July 2025, Category A reimbursement prices will be based on data from suppliers obtained under the Health Service Products (Provision and Disclosure of Information) Regulations 2018. This follows a transition period which took place over six financial quarters from April 2024 to the end of June 2025, with reimbursement prices determined using a variable [...]

The post Category A price-setting arrangements from July 2025 appeared first on Community Pharmacy England.